JJIJ
LUNG icon

Johnson & Johnson Innovation - JJDC’s Pulmonx LUNG Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$249K Hold
5,639
– – 0.03% 20
2021
Q1 		$258K Hold
5,639
– – 0.03% 17
2020
Q4 		$389K Buy
+5,639
New +$276K 0.05% 15

Other funds holding LUNG

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's LUNG Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC held its Pulmonx (LUNG) position steady in Q2 2021 at 5,639 shares worth $249K. The position accounts for 0.03% of the portfolio, ranked #20.

Johnson & Johnson Innovation - JJDC first reported a position in LUNG in Q4 2020 and has held it in 3 quarters since. The position peaked at $389K in Q4 2020. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2021.

  • Johnson & Johnson Innovation - JJDC held 5,639 shares of Pulmonx worth $249K as of Q2 2021.
  • Johnson & Johnson Innovation - JJDC left its Pulmonx share count unchanged in Q2 2021.
  • Pulmonx made up 0.03% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #20 holding.
  • Johnson & Johnson Innovation - JJDC first reported a position in Pulmonx in Q4 2020 and has held it in 3 quarters since.
  • Johnson & Johnson Innovation - JJDC's Pulmonx position peaked at $389K in Q4 2020.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.